Flying The Web For News.
  • New Year's
    New Year's
  • Career Exam Study
    Career Exam Study
  • 2024 Presidential Election
    2024 Presidential Election
  • E-commerce Guide
    E-commerce Guide
  • Dropshipping Guide
    Dropshipping Guide
  • Microsoft Exam
    Microsoft Exam
  • IT Career News
    IT Career News
+ Larger Font | - Smaller Font
Share

Globe NewsWire News Distribution Service


FLORHAM PARK, N.J., Oct. 18, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (the “Company”), a regenerative medicine company developing and commercializing placental-derived technologies, today announced that it has received a formal notice from the Listing Qualifications department of the Nasdaq Stock Market LLC (“Nasdaq”) on October 16, 2024, indicating that the Company is subject to delisting…


Posted: 2024-10-18 22:00:00

Get Full News Story On GlobeNewsWire Press Release Service



Listen to this article. Speaker link opens in a new window.
Text To Speech BETA Test Version.



Related News Stories From The Web And More

Related Bing News Search Results

Press Release: Celularity Inc. Receives Notice from Nasdaq; Confirms Intention to File an Appeal - Newscast

Celularity Inc. (CELU)

Sun, 29 Dec 2024 16:00:00 GMT FLORHAM PARK, N.J., Dec. 10, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq ... today announced that it has received a formal notice from the Listing Qualifications department of the Nasdaq ...

Celularity Inc. (CELUW)

Mon, 09 Dec 2024 16:00:00 GMT Celularity Inc. (Nasdaq: CELU) (the “Company”), a regenerative medicine company developing and commercializing placental-derived technologies, today announced that it has received a formal notice from ...

Celularity Reports Over Sevenfold Growth in Net Product Sales through Third Quarter 2024 Compared to Third Quarter 2023

Fri, 06 Dec 2024 04:59:00 GMT On November 27, 2024, Celularity announced that it received notification from the ... The forward-looking statements in this press release include express or implied statements regarding expected ...

Celularity Reports Over Sevenfold Growth in Net Product Sales through Third Quarter 2024 Compared to Third Quarter 2023

Thu, 05 Dec 2024 16:01:00 GMT On November 27, 2024, Celularity announced that it received notification from the Listing Qualifications department of the Nasdaq Stock Market LLC (“Nasdaq”) stating that Celularity does not ...

Celularity Inc Receives Notice of Non-Compliance with Nasdaq Listing Requirements

Sun, 01 Dec 2024 16:00:00 GMT Celularity Inc (NASDAQ: CELU) recently disclosed in an 8-K filing with the Securities and Exchange Commission (SEC) that it had received notice from the Listing Qualifications department of the ...


Blow Us A Whistle